Stay updated on REFINE: Natalizumab Regimens in Relapsing MS Clinical Trial

Sign up to get notified when there's something new on the REFINE: Natalizumab Regimens in Relapsing MS Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the REFINE: Natalizumab Regimens in Relapsing MS Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    Revision: v3.6.6 replaces the prior v3.6.5 on the page, indicating a minor update to the site’s revision stamp. No user-facing content changes are indicated.
    Difference
    0.0%
    Check dated 2026-08-31T17:14:22.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    No Change Detected
  5. Check
    29 days ago
    Change Detected
    Summary
    A new page revision tag (v3.6.5) was added, updating the page's revision history from v3.6.4. This represents a system-level update and does not modify study content or user-facing information.
    Difference
    0.0%
    Check dated 2026-08-10T07:32:17.000Z thumbnail image
  6. Check
    44 days ago
    Change Detected
    Summary
    The revision label was updated from v3.6.3 to v3.6.4, recording a newer internal version of the page.
    Difference
    0.0%
    Check dated 2026-07-26T13:48:57.000Z thumbnail image
  7. Check
    65 days ago
    Change Detected
    Summary
    The revision label on the page was updated from v3.6.2 to v3.6.3. This signals a minor page/template update rather than any changes to the study details.
    Difference
    0.0%
    Check dated 2026-07-05T04:30:34.000Z thumbnail image
  8. Check
    73 days ago
    Change Detected
    Summary
    The page revision tag changed from v3.6.0 to v3.6.2, representing an internal update to the ClinicalTrials.gov page. Substantive study information remains unchanged.
    Difference
    0.0%
    Check dated 2026-06-27T23:45:24.000Z thumbnail image
  9. Check
    87 days ago
    Change Detected
    Summary
    Recruitment status updated to No longer looking for participants, indicating the study is not enrolling. New help and navigation sections were added (How to Read a Study Record, Common Questions, How to Join a Study), and the Intervention/Treatment heading was adjusted for consistency.
    Difference
    0.3%
    Check dated 2026-06-13T17:16:39.000Z thumbnail image

Stay in the know with updates to REFINE: Natalizumab Regimens in Relapsing MS Clinical Trial

Enter your email address, and we'll notify you when there's something new on the REFINE: Natalizumab Regimens in Relapsing MS Clinical Trial page.